Zacks.com on MSN2d
Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?
Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...
Tempus AI (TEM) Shares Continue Slide Despite Ark Invests Buy-on-the-Dip Efforts
A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...
Tempus AI, Inc. (TEM) Reports Strong Q4 Growth, Fueled by AI-Driven Diagnostics
We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...
Tempus AI: Buying The Dip After 2025 Guidance Raise
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
Tempus AI reports Q4 adjusted EPS (18c), consensus (15c)
Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...
1TEM : Tempus AI Q4 Earnings: Revenue Miss, EPS Beat, Strong Guidance, Shares Move Lower
Would you like to be notified of the latest news and updates on the stock market?
Tempus AI Earnings: A Promising Business, But There Are Risks
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
Hosted on MSN3d
Tempus AI Stock Drops After Company Posts Q4 Results
Tempus AI stock fell late Monday after the medical artificial intelligence company reported fourth-quarter results.